Zyfor-ER Tablet contains Faropenem 200mg, a broad-spectrum oral carbapenem antibiotic effective against a wide range of Gram-positive and Gram-negative bacterial infections. It is primarily indicated for the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, and other bacterial infections caused by susceptible organisms. Faropenem exerts its bactericidal action by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins, leading to cell lysis and death. Zyfor-ER’s extended-release formulation ensures sustained plasma concentrations, enhancing therapeutic efficacy and improving patient compliance by reducing dosing frequency. The drug is well absorbed orally and exhibits a favorable safety profile with minimal adverse effects. It is contraindicated in patients with known hypersensitivity to carbapenems or beta-lactam antibiotics. Caution is advised in patients with a history of seizures or renal impairment, and dosage adjustments may be necessary. Zyfor-ER should be administered as prescribed, completing the full course to prevent the development of resistance. Common side effects may include gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort. Zyfor-ER Tablet offers a potent and convenient option for managing bacterial infections, contributing to improved clinical outcomes when used appropriately.